Compositions and Methods for Modulating S-nitrosogluthione Reductase

Disclosed herein are methods and compositions for modulating the levels and/or activity of S-nitrosoglutathione reductase (GSNOR) in vivo or in vitro. Specifically disclosed are GSNOR deletion constructs, host cells and non-human mammals comprising GSNOR deletions, and methods of screening employing GSNOR deletion mutants. Also specifically disclosed are reagents and procedures for measuring, monitoring, or altering GSNOR levels or activity (as well as nitric oxide and S-nitrosothiol levels) in connection with various medical conditions.

Attached files:


Patents:
US 20,100,266,581

Inventor(s): STAMLER JONATHAN S [US]; LIU LIMIN [US]

Type of Offer: Licensing



« More Medical Patents

---